MUMBAI, India, June 24 -- Intellectual Property India has published a patent application (202617061768 A) filed by Pikavation Therapeutics, Inc. on May 15, 2026, for 5-Oxo-4,5-Dihydroimidazo[1,5-A]quinazoline Compounds As Pi3k[alpha] Inhibitors.
Inventors include Qi, Chao; Zhou, Fei; Li, Yu; Zheng, Hewen; Wu, Liangxing; and Yao, Wenqing.
The application for the patent was published on June 12, 2026, under issue no. 24/2026.
Abstract: The present application provides tricyclic compounds that modulate the activity of the PI3Ka, which are useful in the treatment of various diseases, including cancer.
Disclaimer: Curated by HT Syndication....